The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Open accessAbstract
OBJECTIVE: Accumulating evidence links the intestinal microbiota and colorectal carcinogenesis. Fusobacterium nucleatum may promote colorectal tumour growth and inhibit T cell-mediated immune responses against colorectal tumours. Thus, we hypothesised that the amount of F. nucleatum in colorectal carcinoma might be associated with worse clinical outcome. DESIGN: We used molecular pathological epidemiology database of 1069 rectal and colon cancer cases in the Nurses' Health Study and the Health Professionals Follow-up Study, and measured F. nucleatum DNA in carcinoma tissue. Cox proportional hazards model was used to compute hazard ratio (HR), controlling for potential confounders, including microsatellite instability (MSI, mismatch repair deficiency), CpG island methylator phenotype (CIMP), KRAS, BRAF, and PIK3CA mutations, and LINE-1 hypomethylation (low-level methylation). RESULTS: Compared with F. nucleatum-negative cases, multivariable HRs (95% CI) for colorectal cancer-specific mortality in F. nucleatum-low cases and F. nucleatum-high cases were 1.25 (0.82 to 1.92) and 1.58 (1.04 to 2.39), respectively, (p for trend=0.020). The amount of F. nucleatum was associated with MSI-high (multivariable odd ratio (OR), 5.22; 95% CI 2.86 to 9.55) independent of CIMP and BRAF mutation status, whereas CIMP and BRAF mutation were associated with F. nucleatum only in univariate analyses (p<0.001) but not in multivariate analysis that adjusted for MSI status. CONCLUSIONS: The amount of F. nucleatum DNA in colorectal cancer tissue is associated with shorter survival, and may potentially serve as a prognostic biomarker. Our data may have implications in developing cancer prevention and treatment strategies through targeting GI microflora by diet, probiotics and antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Numerous studies, of multiple cohorts, of patients with CRC worldwide have found similar associations.23–27”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Self-citationRubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Self-citationGur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.010 · Cited by 1,490
Self-citationLong-term colorectal-cancer incidence and mortality after lower endoscopy
Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z. R., Inamura, K., Kim, S. A., Kuchiba, A., Yamauchi, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301969 · Cited by 1,483
Self-citationGarrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
Self-citationSystemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,080
Self-citationSystemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Cited by
Sorted by citations
Items 101–200 of 1,000
Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity
Meng, Q., Gao, Q., Mehrazarin, S., Tangwanichgapong, K., Wang, Y., Huang, Y., Pan, Y., Robinson, S. T., Liu, Z., Zangiabadi, A., et al. (2021) · EMBO Reports · doi:10.15252/embr.202152891 · Cited by 153
Metabolic and Community Synergy of Oral Bacteria in Colorectal Cancer
Flynn, K. J., Baxter, N. T., & Schloss, P. D. (2016) · mSphere · doi:10.1128/msphere.00102-16 · Cited by 156
Fan, Z., Tang, P., Li, C., Yang, Q., Xu, Y., Su, C., & Li, L. (2023) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2145729 · Cited by 150
Huang, Z., Chen, J., Li, B., Zeng, B., Chou, C., Zheng, X. M., Xie, J., Li, H., Yu, H., Chen, G., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216471 · Cited by 148
Gut Microbiota, Fusobacteria, and Colorectal Cancer
Kelly, D., Yang, L., & Pei, Z. (2018) · Diseases · doi:10.3390/diseases6040109 · Cited by 152
Linking Gut Microbiota to Colorectal Cancer
Raskov, H., Burcharth, J., & Pommergaard, H. (2017) · Journal of Cancer · doi:10.7150/jca.20497 · Cited by 158
The gut microbiome: what the oncologist ought to know
Lee, K. A., Luong, M., Shaw, H. M., Nathan, P., Bataille, V. A., & Spector, T. D. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01467-x · Cited by 154
Udayasuryan, B., Nguyen, T. T. D., Nguyen, T. T. D., Umaña, A., Roberts, L. M., Sobol, P., Jones, S. D., Munson, J. M., Slade, D. J., & Verbridge, S. S. (2022) · Science Signaling · doi:10.1126/scisignal.abn4948 · Cited by 152
Hu, L., Liu, Y., Kong, X., Wu, R., Peng, Q., Zhang, Y., Zhou, L., & Duan, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658681 · Cited by 144
Amitay, E. L., Werner, S., Vital, M., Pieper, D. H., Höfler, D., Gierse, I.-J., Butt, J., Balavarca, Y., Ćuk, K., & Brenner, H. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx053 · Cited by 141
Colorectal cancer and gut microbiota studies in China
Wang, Z., Dan, W., Zhang, N., Fang, J., & Yang, Y. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2236364 · Cited by 151
Microbial markers in colorectal cancer detection and/or prognosis
Villéger, R., Lopès, A., Véziant, J., Gagnière, J., Barnich, N., Billard, E., Boucher, D., & Bonnet, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i22.2327 · Cited by 146
Fusobacterium and Colorectal Cancer
Zhou, Z., Chen, J., Yao, H., & Hu, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00371 · Cited by 140
The microbiome and cancer for clinicians
Picardo, S. L., Coburn, B. A., & Hansen, A. R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.06.004 · Cited by 141
Sivaprakasam, S., Gurav, A., Paschall, A. V., Coe, G. L., Chaudhary, K., Cai, Y., Kolhe, R. B., Martin, P. M., Browning, D. D., Huang, L., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.38 · Cited by 135
The microbiome and hepatobiliary-pancreatic cancers
Mima, K., Nakagawa, S., Sawayama, H., Ishimoto, T., Imai, K., Iwatsuki, M., Hashimoto, D., Baba, Y., Yamashita, Y., Yoshida, N., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.001 · Cited by 136
Self-citationGethings-Behncke, C., Coleman, H. G., Jordão, H. W. T., Longley, D. B., Crawford, N., Murray, L., & Kunzmann, A. T. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1295 · Cited by 145
Intestinal bacteria and colorectal cancer: etiology and treatment
Dougherty, M. W., & Jobin, C. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2185028 · Cited by 145
Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota
Loke, Y. L., Chew, M. T., Ngeow, Y. F., Lim, W. W.-D., & Peh, S. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.603086 · Cited by 138
Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism
Ou, S., Wang, H., Tao, Y., Luo, K., Ye, J., Ran, S., Guan, Z., Wang, Y., Hu, H., & Huang, R. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1020583 · Cited by 139
Microbial Metabolites and Gut Immunology
Takeuchi, T., Nakanishi, Y., & Ohno, H. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090222-102035 · Cited by 143
Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression
Lopez, L. R., Bleich, R. M., & Arthur, J. C. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-080719-091604 · Cited by 136
Wang, S., Liu, Y., Li, J., Zhao, L., Yan, W., Lin, B., Guo, X., & Wei, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.710165 · Cited by 132
Mucosa-associated microbiota signature in colorectal cancer
Gao, R., Kong, C., Huang, L., Li, H., Qu, X., Liu, Z., Lan, P., Wang, J., & Qin, H. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3026-4 · Cited by 123
Hale, V. L., Jeraldo, P., Chen, J., Mundy, M. B., Yao, J. Z., Priya, S., Keeney, G., Lyke, K. J., Ridlon, J. M., White, B. A., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0586-6 · Cited by 127
Wolf, P. G., Cowley, E. S., Breister, A. M., Matatov, S., Lucio, L., Polak, P., Ridlon, J. M., Gaskins, H. R., & Anantharaman, K. (2022) · Microbiome · doi:10.1186/s40168-022-01242-x · Cited by 126
Cancer metastasis: Molecular mechanisms and clinical perspectives
Khan, S. U., Fatima, K., Malik, F. A., Kalkavan, H., & Wani, A. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108522 · Cited by 127
Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy
Drewes, J. L., Housseau, F., & Sears, C. L. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.189 · Cited by 121
Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
Temraz, S. N., Nassar, F. J., Nasr, R., Charafeddine, M., Mukherji, D., & Shamseddine, A. I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174155 · Cited by 125
The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management
Sun, C., Li, B., Wang, B., Zhao, J., Zhang, X., Li, T., Li, W., Tang, D., Qiu, M., Wang, X., et al. (2019) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2019.09.001 · Cited by 125
Self-citationLiu, L., Tabung, F. K., Zhang, X., Nowak, J. A., Qian, Z. R., Hamada, T., Nevo, D., Bullman, S., Mima, K., Kosumi, K., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.030 · Cited by 118
Self-citationMicrobiota in cancer development and treatment
Raza, M. H., Gul, K., Arshad, A., Riaz, N., Waheed, U., Rauf, A., Aldakheel, F. M., Alduraywish, S. A., Rehman, M. U., Abdullah, M., et al. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2816-0 · Cited by 122
Montalban‐Arques, A., & Scharl, M. M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.050 · Cited by 118
Gut Microbiota in Intestinal and Liver Disease
Jones, R. M., & Neish, A. S. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-030320-095722 · Cited by 117
Exploring the oral-gut linkage: Interrelationship between oral and systemic diseases
Yamazaki, K., & Kamada, N. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.11.006 · Cited by 117
Sun, J., Tang, Q., Yu, S., Xie, M., Zheng, W., Chen, G., Yin, Y., Huang, X., Wo, K., Lei, H., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104444 · Cited by 121
Gomes, S., Oliveira, C. S., Azevedo‐Silva, J., Casanova, M. R., Barreto, J., Pereira, H., Chaves, S. R., Rodrigues, L. R., Casal, M., Côrte‐Real, M., et al. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180530102050 · Cited by 116
Hamada, T., Keum, N., Nishihara, R., & Ogino, S. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1272-3 · Cited by 115
Self-citationThe gut microbiome and cancer: from tumorigenesis to therapy
Nobels, A., van Marcke, C., Jordan, B. F., Hul, M. V., & Cani, P. D. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01287-w · Cited by 126
Integrated approaches for precision oncology in colorectal cancer: The more you know, the better
Andrei, P., Battuello, P., Grasso, G., Rovera, E., Tesio, N., & Bardelli, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.007 · Cited by 116
Nomoto, D., Baba, Y., Liu, Y., Tsutsuki, H., Okadome, K., Harada, K., Ishimoto, T., Iwatsuki, M., Iwagami, S., Miyamoto, Y., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.01.014 · Cited by 117
Self-citationGut microbiota-mediated immunomodulation in tumor
Liu, X., Chen, Y., Zhang, S., & Dong, L. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01983-x · Cited by 112
Wang, J., Liu, Z., Xu, Y., Wang, Y., Wang, F., Zhang, Q., Ni, C., Yi, Z., Xu, R. C., Liu, Q., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.913815 · Cited by 116
Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
Li, S., Liu, J., Zheng, X., Ren, L., Yang, Y., Li, W., Fu, W., Wang, J., & Du, G. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0651 · Cited by 116
The colorectal cancer immune microenvironment and approach to immunotherapies
Koi, M., & Carethers, J. M. (2017) · Future Oncology · doi:10.2217/fon-2017-0145 · Cited by 113
Tea polyphenols and their chemopreventive and therapeutic effects on colorectal cancer
Wang, S.-T., Cui, W., Pan, D., Jiang, M., Chang, B., & Sang, L.-X. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i6.562 · Cited by 112
Yan, X., Liu, L., Li, H., Qin, H., & Sun, Z. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s145949 · Cited by 112
Zheng, X., Liu, R., Zhou, C., Yu, H., Luo, W., Zhu, J., Liu, J., Zhang, Z., Xie, N., Peng, X., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-2273 · Cited by 105
Park, H. E., Kim, J. H., Cho, N., Lee, H. S., & Kang, G. H. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2171-6 · Cited by 105
Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
Mulet-Margalef, N., Linares, J., Badia-Ramentol, J., Jimeno, M., Sanz, C., Mozo, J. L. M., & Calon, A. (2023) · Cancers · doi:10.3390/cancers15041022 · Cited by 112
Metabolite and Microbiome Interplay in Cancer Immunotherapy
Johnson, C. H., Spilker, M. E., Goetz, L. H., Peterson, S. N., & Siuzdak, G. E. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0309 · Cited by 109
Borowsky, J., Haruki, K., Lau, M. C., Costa, A. D., Väyrynen, J. P., Ugai, T., Arima, K., da Silva, A., Felt, K. D., Zhao, M. M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4009 · Cited by 110
Self-citationMouradov, D., Greenfield, P. A., Li, S., In, E.-J., Storey, C., Sakthianandeswaren, A., Georgeson, P., Buchanan, D. D., Ward, R. L., Hawkins, N. J., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.03.205 · Cited by 105
Wang, H., Li, L., Guo, S., Zeng, Q., Ning, F., Liu, W., & Zhang, G. (2016) · Scientific Reports · doi:10.1038/srep33440 · Cited by 105
Clinical applications of gut microbiota in cancer biology
Wong, S. H., Kwong, T. N. Y., Wu, C., & Yu, J. Q. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.05.003 · Cited by 102
Ševčíková, A., Izoldova, N., Števurková, V., Kasperova, B., Chovanec, M., Čierniková, S., & Mego, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010488 · Cited by 109
Hamada, T., Nowak, J. A., Milner, D. A., Song, M., & Ogino, S. (2019) · The Journal of Pathology · doi:10.1002/path.5236 · Cited by 100
Self-citationChen, C., Wang, Z., Wang, J., Ding, C., Sun, C., Liu, P., Xu, X., Liu, Y., Chen, B., & Gu, B. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-19-590 · Cited by 97
Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer
Clos‐Garcia, M., García‐Etxebarria, K., Alonso, C., Iruarrizaga‐Lejarreta, M., D’Amato, M., Crespo, A., Iglesias, Á., Cubiella, J., Bujanda, L., & Falcón‐Pérez, J. M. (2020) · Cancers · doi:10.2139/ssrn.3520024 · Cited by 99
Olvera-Rosales, L. B., Cruz-Guerrero, A. E., Ramírez‐Moreno, E., Lira, A. Q., Contreras‐López, E., Ordaz, J. J., Ovando, A. C., Añorve‐Morga, J., Calderón‐Ramos, Z. G., Arias‐Rico, J., et al. (2021) · Foods · doi:10.3390/foods10061261 · Cited by 108
Integration of molecular pathology, epidemiology and social science for global precision medicine
Nishi, A., Milner, D. A., Giovannucci, E. L., Nishihara, R., Tan, A. S. L., Kawachi, I. I., & Ogino, S. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1115346 · Cited by 98
Self-citationGut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence
Vacante, M., Ciuni, R., Basile, F., & Biondi, A. (2020) · Biomedicines · doi:10.3390/biomedicines8110489 · Cited by 98
Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression
Torres-Maravilla, E., Boucard, A.-S., Mohseni, A. H., Taghinezhad‐S, S., Cortes‐Perez, N. G., & Bermúdez‐Humarán, L. G. (2021) · Microorganisms · doi:10.3390/microorganisms9051021 · Cited by 98
Lee, D., Han, S., Kang, J., Bae, J. M., Kim, H., Won, J., Jeong, S., Park, K. J., Kang, G. H., & Kim, T. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6681-5 · Cited by 95
Ranjbar, M., Salehi, R., Javanmard, S. H., Rafiee, L., Faraji, H., jafarpor, S., Ferns, G. A., Ghayour‐Mobarhan, M., Manian, M., & Nedaeinia, R. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01886-z · Cited by 101
Wu, Y., Wu, J., Chen, T., Li, Q., Peng, W., Li, H., Tang, X., & Fu, X. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-4999-2 · Cited by 94
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Mekadim, C., Skalníková, H. K., Čížková, J., Cizkova, V., Palanová, A., Horák, V., & Mrázek, J. (2022) · BMC Microbiology · doi:10.1186/s12866-022-02458-5 · Cited by 99
Neoadjuvant treatment of colorectal cancer: comprehensive review
Smith, H. G., Nilsson, P. J., Shogan, B. D., Harji, D. P., Gambacorta, M. A., Romano, Â., Brandl, A., & Qvortrup, C. (2024) · BJS Open · doi:10.1093/bjsopen/zrae038 · Cited by 103
The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesis
Zhang, L., Leng, X.-X., Qi, J., Wang, N., Han, J., Tao, Z., Zhuang, Z.-Y., Ren, Y., Xie, Y., Jiang, S., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01784-w · Cited by 98
Viral oncogenesis in cancer: from mechanisms to therapeutics
Xiao, Q., Liu, Y., Li, T., Wang, C., He, S., Zhai, L., Yang, Z., Zhang, X., Wu, Y., & Liu, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02197-9 · Cited by 111
Lucas, C., Salesse, L., Hoang, M. H. T., Bonnet, M., Sauvanet, P., Larabi, A. B., Godfraind, C., Gagnière, J., Pezet, D., Rosenstiel, P. C., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.026 · Cited by 98
Zhu, G., Huang, Q., Huang, Y., Zheng, W., Jin, H., Yang, S., Zhuang, J., Wang, J., & Ye, J. (2016) · Oncotarget · doi:10.18632/oncotarget.12449 · Cited by 91
Inamura, K., Hamada, T., Bullman, S., Ugai, T., Yachida, S., & Ogino, S. (2022) · Gut · doi:10.1136/gutjnl-2022-327209 · Cited by 97
Self-citationGut microbiome: a new player in gastrointestinal disease
Gorkiewicz, G., & Moschen, A. R. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2277-x · Cited by 95
Microbiome epidemiology and association studies in human health
VanEvery, H., Franzosa, E. A., Nguyen, L. H., & Huttenhower, C. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00529-x · Cited by 86
Self-citationQu, X., Yin, F., Pei, M., Chen, Q., Zhang, Y., Lu, S., Zhang, X., Liu, Z., Li, X., Chen, H., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c01308 · Cited by 88
The Role of Diet and Lifestyle in Early-Onset Colorectal Cancer: A Systematic Review
Puzzono, M., Mannucci, A., Grannò, S., Zuppardo, R. A., Galli, A., Danese, S., & Cavestro, G. M. (2021) · Cancers · doi:10.3390/cancers13235933 · Cited by 92
Zhu, H., Li, M., Bi, D., Yang, H., Gao, Y., Song, F., Zheng, J., Xie, R., Zhang, Y., Liu, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45572-w · Cited by 93
Burns, M. B., Montassier, E., Abrahante, J. E., Priya, S., Niccum, D. E., Khoruts, A., Starr, T. K., Knights, D., & Blekhman, R. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007376 · Cited by 87
Mucins, gut microbiota, and postbiotics role in colorectal cancer
Pothuraju, R., Chaudhary, S., Rachagani, S., Kaur, S., Roy, H. K., Bouvet, M., & Batra, S. K. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1974795 · Cited by 89
Pathogenic factors inCandidabiofilm-related infectious diseases
Hirota, K., Yumoto, H., Bayarmagnai, S., Matsuo, T., Ichikawa, T., & Miyake, Y. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13330 · Cited by 85
Microbiome-driven carcinogenesis in colorectal cancer: Models and mechanisms
Wang, X., Yang, Y., & Huycke, M. M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.504 · Cited by 86
Kosumi, K., Hamada, T., Koh, H., Borowsky, J., Bullman, S., Twombly, T. S., Nevo, D., Masugi, Y., Liu, L., da Silva, A., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.08.015 · Cited by 85
Self-citationPignatelli, P., Romei, F. M., Bondi, D., Giuliani, M., Piattelli, A., & Curia, M. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158323 · Cited by 90
Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum
Brennan, C. A., Nakatsu, G., Gallini, C. A., Drew, D. A., Glickman, J. N., Schoen, R. E., Chan, A. T., & Garrett, W. S. (2021) · mBio · doi:10.1128/mbio.00547-21 · Cited by 81
Self-citationChen, Z., Wong, P. Y., Ng, C. W. K., Lan, L., Fung, S. Y. H., Li, J. W., Cai, L., Lei, P., Mou, Q., Wong, S. H., et al. (2020) · Cancers · doi:10.3390/cancers12113425 · Cited by 78
Self-citationJoo, J. E., Chu, Y. L., Georgeson, P., Walker, R., Mahmood, K., Clendenning, M., Meyers, A. L., Como, J., Joseland, S. L., Preston, S., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-023-02554-x · Cited by 84
Burgos-Molina, A. M., Santana, T. T., Redondo, M., & Romero, M. J. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116188 · Cited by 87
Ai, L., Tian, H., Chen, Z., Chen, H., Xu, J., & Fang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14488 · Cited by 78
Mima, K., Ogino, S., Nakagawa, S., Sawayama, H., Kinoshita, K., Krashima, R., Ishimoto, T., Imai, K., Iwatsuki, M., Hashimoto, D., et al. (2017) · Surgical Oncology · doi:10.1016/j.suronc.2017.07.011 · Cited by 80
Self-citationYamamoto, H., & Imai, K. (2019) · Seminars in Oncology · doi:10.1053/j.seminoncol.2019.08.003 · Cited by 75
Koi, M., Okita, Y., & Carethers, J. M. (2018) · Journal of the Anus Rectum and Colon · doi:10.23922/jarc.2017-055 · Cited by 78
Sociodemographic variation in the oral microbiome
Renson, A., Jones, H. E., Beghini, F., Segata, N., Zolnik, C. P., Usyk, M., Moody, T. U., Thorpe, L. E., Burk, R. D., Waldron, L., et al. (2019) · Annals of Epidemiology · doi:10.1016/j.annepidem.2019.03.006 · Cited by 75
Fusobacterium’s link to colorectal neoplasia sequenced: A systematic review and future insights
Hussan, H., Clinton, S. K., Roberts, K., & Bailey, M. T. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i48.8626 · Cited by 76
Kim, S. Y., Han, Y. K., Song, J. M., Lee, C. H., Kang, K., Yi, J. M., & Park, H. R. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0715-0 · Cited by 75
Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
Singh, S., Sharma, P., Sarma, D. K., Kumawat, M., Tiwari, R. R., Verma, V., Nagpal, R., & Kumar, M. (2023) · Cancers · doi:10.3390/cancers15061913 · Cited by 83
Yamamura, K., Baba, Y., Miyake, K., Nakamura, K., Shigaki, H., Mima, K., Kurashige, J., Ishimoto, T., Iwatsuki, M., Sakamoto, Y., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.7001 · Cited by 74
Self-citationBioactive Nutrients and Nutrigenomics in Age-Related Diseases
Rescigno, T., Micolucci, L., Tecce, M. F., & Capasso, A. (2017) · Molecules · doi:10.3390/molecules22010105 · Cited by 75
Véziant, J., Villéger, R., Barnich, N., & Bonnet, M. (2021) · Cancers · doi:10.3390/cancers13092215 · Cited by 76
The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease
Ocansey, D. K. W., Hang, S., Yuan, X., Qian, H., Zhou, M., Olovo, C. V., Zhang, X., & Mao, F. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2176118 · Cited by 71
Metadata
- Authors
- Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., Kostic, A. D., Giannakis, M., Bullman, S., Milner, D. A., Baba, H., Giovannucci, E. L., Garraway, L. A., Freeman, G. J., Dranoff, G., Garrett, W. S., Huttenhower, C., Meyerson, M., Meyerhardt, J. A., Chan, A. T., Fuchs, C. S., & Ogino, S.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Kumamoto University (JP)
- Corresponding author
- Ogino, Shuji
- ORCID
- Mima, Kosuke
- Nishihara, Reiko
- Qian, Zhi Rong
- Cao, Yin
- Sukawa, Yasutaka
- Nowak, Jonathan A
- Yang, Juhong
- Dou, Ruoxu
- Masugi, Yohei
- Song, Mingyang
- Kostic, Aleksandar D
- Giannakis, Marios
- Bullman, Susan
- Milner, Danny A
- Baba, Hideo
- Giovannucci, Edward L
- Garraway, Levi A
- Freeman, Gordon J
- Dranoff, Glenn
- Garrett, Wendy S
- Huttenhower, Curtis
- Meyerson, Matthew
- Meyerhardt, Jeffrey A
- Chan, Andrew T
- Fuchs, Charles S
- Ogino, Shuji
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2015-08-26
- Volume
- 65
- Issue
- 12
- Pages
- 1973-1980
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC4769120
- OpenAlex
- W2199896469
- Cited by
- 1,080
- References
- 53
- Citations by year
- 2026: 108 · 2025: 116 · 2024: 131 · 2023: 119 · 2022: 141 · 2021: 140 · 2020: 105 · 2019: 71 · 2018: 64 · 2017: 47 · 2016: 34 · 2015: 4
- FWCI
- 21.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (KL2TR001100)
- National Cancer Institute (P50CA127003, R01CA151993, R01CA118553, R01CA137178, R35CA197735, P01CA087969, R01CA169141, K07CA122826, P01CA055075, UM1CA186107, UM1CA167552, K07CA190673, R01CA154426)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK098311)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- Fusobacterium nucleatum, colorectal cancer, rectal cancer, colon cancer, prognosis, colorectal cancer-specific mortality, tumor microbiome, microsatellite instability, CpG island methylator phenotype, BRAF mutation, prognostic factors, gut microbiota, antitumor immunity
- MeSH terms
- Aged, Carcinoma, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mutation, Neoplasm Staging, Phenotype, Prognosis, Prospective Studies, Research Design, Biomarkers, Tumor, Colorectal Neoplasms, Databases, Factual, Proto-Oncogene Proteins p21(ras), Fusobacterium nucleatum, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins B-raf, Kaplan-Meier Estimate, Microsatellite Instability, Class I Phosphatidylinositol 3-Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
